Results 231 to 240 of about 1,739,286 (305)

Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation

Proceedings of the National Academy of Sciences of the United States of America, 2013
M. Gerlic, B. Faustin, A. Postigo, E. Yu, M. Proell, Naran Gombosuren, M. Krajewska, R. Flynn, M. Croft, M. Way, A. Satterthwait, R. Liddington, Shahram Salek-Ardakani, S. Matsuzawa, John Calvin Reed   +14 more
semanticscholar   +1 more source

Structure and flexibility of the DNA polymerase holoenzyme of vaccinia virus. [PDF]

PLoS Pathog
Burmeister WP, Boutin L, Balestra AC, Gröger H, Ballandras-Colas A, Hutin S, Kraft C, Grimm C, Böttcher B, Fischer U, Tarbouriech N, Iseni F.   +11 more
europepmc   +1 more source

Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer

Proceedings of the National Academy of Sciences of the United States of America, 2013
J. Stritzker, Lorenz Kirscher, Miriam Scadeng, N. Deliolanis, S. Morscher, Panagiotis Symvoulidis, Karin Schaefer, Qian Zhang, L. Buckel, Michael Hess, U. Donat, W. Bradley, V. Ntziachristos, A. Szalay   +13 more
semanticscholar   +1 more source

A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells. [PDF]

PLoS One
Okita G, Suenaga K, Sakaguchi M, Murakami T.   +3 more
europepmc   +1 more source

Treatment with oncolytic vaccinia virus infects tumor-infiltrating regulatory and exhausted T cells. [PDF]

J Immunother Cancer
DePeaux K, Gunn WG, Rivadeneira DB, Delgoffe GM.   +3 more
europepmc   +1 more source

Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A-Armed Modified Ankara-Vaccinia Virus Vectored Vaccines in Nasopharyngeal Cancer. [PDF]

Pharmaceutics
Sun L, Liu C, Peng J.
europepmc   +1 more source

Adsorption Experiments with the Virus of Vaccinia [PDF]

Journal of Bacteriology, 1932
openaire   +3 more sources

Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. [PDF]

Signal Transduct Target Ther
Mayer L, Weskamm LM, Addo MM.
europepmc   +1 more source

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. [PDF]

Signal Transduct Target Ther
Mayer L, Weskamm LM, Addo MM.
europepmc   +1 more source

Enhancing the efficiency of oncolytic vaccinia virus for ovarian cancer treatment

Drymiotou S, Queval CJ, Tyson KE, Sheach LA, Postigo A, Rosa ID, Howell M, McNeish IA, Way M.   +8 more
europepmc   +1 more source